Vitamin D in pediatric patients with obesity and arterial hypertension

Abstract The purpose of this study was to find potential differences in vitamin D levels between different groups: overweight children with hypertension, normal-weight children with hypertension, overweight children with normal blood pressure and normal-weight children without hypertension, represen...

Full description

Bibliographic Details
Main Authors: Živa Radulović, Zarja Polak Zupan, Aljoša Tomazini, Nataša Marčun Varda
Format: Article
Language:English
Published: Nature Publishing Group 2021-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-98993-8
id doaj-fc30a377eb824401a8f10fc68afedf28
record_format Article
spelling doaj-fc30a377eb824401a8f10fc68afedf282021-10-03T11:32:15ZengNature Publishing GroupScientific Reports2045-23222021-10-011111810.1038/s41598-021-98993-8Vitamin D in pediatric patients with obesity and arterial hypertensionŽiva Radulović0Zarja Polak Zupan1Aljoša Tomazini2Nataša Marčun Varda3Medical Faculty, University of MariborMedical Faculty, University of MariborMedical Faculty, University of MariborMedical Faculty, University of MariborAbstract The purpose of this study was to find potential differences in vitamin D levels between different groups: overweight children with hypertension, normal-weight children with hypertension, overweight children with normal blood pressure and normal-weight children without hypertension, representing the control group. We also wanted to determine whether there are correlations between vitamin D levels and other clinical laboratory parameters, to evaluate the potential need for substitution. We measured vitamin D, homocysteine, total cholesterol, HDL, LDL, triglycerides, uric acid, glucose, apolipoprotein A1, apolipoprotein B, alkaline phosphatase, calcium, phosphate and magnesium serum levels in all groups. We also took anthropometric measurements (body weight, height, body mass index (BMI)) and observed patients’ blood pressure. The results were analyzed with SPSS statistic tool with basic statistical methods. The study included 175 children between 5 and 18 years of age. Fiftyseven were healthy (group A—control group), 41 normal-weight with hypertension (group B), 44 overweight with hypertension (group C) and 33 overweight with normal blood pressure (group D). The results showed statistically significant differences in values of vitamin D between all groups—A and B (p = 0.003), A and C (p < 0.001), A and D (p < 0.001), B and D (p = 0.043), B and C (0.030), except for groups C and D (p = 0.830). There were statistically significant correlations between vitamin D and BMI (r = − 0.196, p = 0.010), systolic pressure (r = − 0.190, p = 0.002), diastolic pressure (r = − 0.149, p = 0.050), homocysteine (r = − 0.208, p = 0.007), triglycerides (r = − 0.196, p = 0.011) and apolipoprotein A1 (r = 0.222, p = 0.007), confirmed in multivariate model. For the blood pressure, the higher the systolic blood pressure, the lower the average vitamin D was. The pilot study shows significant differences in serum vitamin D levels between all groups of children, apart from groups C and D. These results, combined with statistically significant correlations between vitamin D and systolic and diastolic blood pressure suggest the need for monitoring and potential substitution of vitamin D in in pediatric patients with hypertension.https://doi.org/10.1038/s41598-021-98993-8
collection DOAJ
language English
format Article
sources DOAJ
author Živa Radulović
Zarja Polak Zupan
Aljoša Tomazini
Nataša Marčun Varda
spellingShingle Živa Radulović
Zarja Polak Zupan
Aljoša Tomazini
Nataša Marčun Varda
Vitamin D in pediatric patients with obesity and arterial hypertension
Scientific Reports
author_facet Živa Radulović
Zarja Polak Zupan
Aljoša Tomazini
Nataša Marčun Varda
author_sort Živa Radulović
title Vitamin D in pediatric patients with obesity and arterial hypertension
title_short Vitamin D in pediatric patients with obesity and arterial hypertension
title_full Vitamin D in pediatric patients with obesity and arterial hypertension
title_fullStr Vitamin D in pediatric patients with obesity and arterial hypertension
title_full_unstemmed Vitamin D in pediatric patients with obesity and arterial hypertension
title_sort vitamin d in pediatric patients with obesity and arterial hypertension
publisher Nature Publishing Group
series Scientific Reports
issn 2045-2322
publishDate 2021-10-01
description Abstract The purpose of this study was to find potential differences in vitamin D levels between different groups: overweight children with hypertension, normal-weight children with hypertension, overweight children with normal blood pressure and normal-weight children without hypertension, representing the control group. We also wanted to determine whether there are correlations between vitamin D levels and other clinical laboratory parameters, to evaluate the potential need for substitution. We measured vitamin D, homocysteine, total cholesterol, HDL, LDL, triglycerides, uric acid, glucose, apolipoprotein A1, apolipoprotein B, alkaline phosphatase, calcium, phosphate and magnesium serum levels in all groups. We also took anthropometric measurements (body weight, height, body mass index (BMI)) and observed patients’ blood pressure. The results were analyzed with SPSS statistic tool with basic statistical methods. The study included 175 children between 5 and 18 years of age. Fiftyseven were healthy (group A—control group), 41 normal-weight with hypertension (group B), 44 overweight with hypertension (group C) and 33 overweight with normal blood pressure (group D). The results showed statistically significant differences in values of vitamin D between all groups—A and B (p = 0.003), A and C (p < 0.001), A and D (p < 0.001), B and D (p = 0.043), B and C (0.030), except for groups C and D (p = 0.830). There were statistically significant correlations between vitamin D and BMI (r = − 0.196, p = 0.010), systolic pressure (r = − 0.190, p = 0.002), diastolic pressure (r = − 0.149, p = 0.050), homocysteine (r = − 0.208, p = 0.007), triglycerides (r = − 0.196, p = 0.011) and apolipoprotein A1 (r = 0.222, p = 0.007), confirmed in multivariate model. For the blood pressure, the higher the systolic blood pressure, the lower the average vitamin D was. The pilot study shows significant differences in serum vitamin D levels between all groups of children, apart from groups C and D. These results, combined with statistically significant correlations between vitamin D and systolic and diastolic blood pressure suggest the need for monitoring and potential substitution of vitamin D in in pediatric patients with hypertension.
url https://doi.org/10.1038/s41598-021-98993-8
work_keys_str_mv AT zivaradulovic vitamindinpediatricpatientswithobesityandarterialhypertension
AT zarjapolakzupan vitamindinpediatricpatientswithobesityandarterialhypertension
AT aljosatomazini vitamindinpediatricpatientswithobesityandarterialhypertension
AT natasamarcunvarda vitamindinpediatricpatientswithobesityandarterialhypertension
_version_ 1716845469178527744